← Leaderboards
Kirsten Williams
Emory University
$1,456,857
Attributed
$2,913,713
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $644.6K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,913,713 · 1
By mechanism
R01$2,913,713 · 1
Top collaborators
- Jennifer Lin Holter Chakrabarty5 shared
Most similar at Emory University
Same institution · by research overlap
- Christian P Larsen$35,318,088
- Leslie S Kean$43,609,566
- Stephen Pastan$3,206,213
- Kimberly Ruth Jacob Arriola$7,488,358
- Edmund K. Waller$12,096,498
Others in their field
Other Emerging Leaders on “Growth”
- Prasant Mohapatra · University Of California At Davis$41,945,816
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
- Jeffrey Reich · Sparian Biosciences, Inc.$13,729,307
- Gary Fanger · Rise Therapeutics, Llc$13,256,050
- Maurizio Macaluso · Cincinnati Childrens Hosp Med Ctr$12,355,450
Research focus
GrowthGraft FailureBiological MarkersFinancial HardshipBloodAllogenicBone Marrow PurgingCellsAdultChemotherapyChestCirculating BiomarkersBone MarrowCohortComplicationCostDiagnosisDonor PersonCessation Of LifeEngraftmentEnrollmentEnzymesFailureHematology
Grant awards (5)
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$581,140
R01 · FY2023 · HL · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$569,118
R01 · FY2022 · HL · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$565,274
R01 · FY2021 · HL · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$553,550
R01 · FY2020 · HL · contact PI
Imaging and Blood Biomarkers to Predict Graft Failure after HSCT$644,631
R01 · FY2019 · HL · contact PI